Plaque Erosion with No Stenting in Acute Coronary Syndrome: Are There Event Predictors to Avoid This Strategy?

 Event predictors in patients with plaque erosion and no stenting.


A third of all acute coronary syndrome (ACS) cases are caused by plaque erosion. In the initial EROSION study, it was shown that patients with plaque erosion (as evidenced by OCT, with stenosis <70%, TIMI III flow, and asymptomatic) were stabilized without stent implantation (no stenting strategy), with antiplatelet therapy using aspirin and ticagrelor. In turn, the 4-year follow-up of this study showed an incidence of major adverse cardiovascular events (MACE) of 23.1%.

Erosión de placa con “no stenting” en el síndrome coronario agudo: ¿Existen predictores de eventos para evitar esta estrategia?

The aim of the study by Yin Y. et al. was to compare the predictors of adverse events with this type of strategy in a retrospective cohort from one center and the historical cohort of the EROSION study (232 patients in total). Patients were divided into two groups according to the occurrence or not of MACE. Patients with ST-elevation, non-ST-elevation, and unstable angina (pretreated with aspirin, ticagrelor, and unfractionated heparin) were included.

Of the 232 ACS patients included, 21.6% had experienced a MACE event (composite outcome of cardiac death, recurrent acute myocardial infarction, ischemia-guided revascularization, rehospitalization for angina, major bleeding, or stroke) at the 2.9-year follow-up. Patients with MACE were older (55.7 vs. 51 years; p = 0.004) and with higher prevalence of diabetes (18% vs. 8.8%; p = 0.063). When analyzing OCT data, those patients with events had lower prevalence of presence of a fibrous plaque (6% vs. 22%, p = 0.010), higher thrombotic burden (24.4% vs. 20.4%; p = 0.010), smaller minimal luminal area (2.3 vs. 2.9, p = 0.001), and higher stenosis area percentage (SA%) (72.2% vs. 64.2%, p ≤ 0.001).

Read also: Uncomplicated Type B Aortic Dissection.

With a multivariate analysis, researchers observed that age (hazard ratio [HR]: 1.035; 95% confidence interval [CI]: 1.005-1.065; = 0.021), SA% (HR: 1.043; 95% CI: 1.015-1.071; p = 0.003) and thrombotic burden (HR: 1.026; 95% CI: 1.001-1.053; p = 0.044) were event predictors. In turn, they analyzed with an ROC curve the best cutoff points for the definition of events, which were age >60 years, SA% ≥63.5%, and thrombotic burden ≥18.5%. The MACE rate with these three predictors present was 57.7%.

Conclusions

Patients with ACS selected for the no stenting strategy had a MACE rate of 21.6%, with the predictors for clinical outcomes being age >60 years, SA% >63.5%, and thrombotic burden >18.5%. Therefore, these characteristics should be taken into account before deciding to omit stenting.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the editorial board of SOLACI.org.

Original Title: Predictors of Adverse Prognosis in Patients With Acute Coronary Syndrome Caused by Plaque Erosion With a Nonstent Strategy.

Reference: Yin Y, Lei F, Fang C, Jiang S, Xu X, Sun S, Pei X, Jia R, Tang C, Peng C, Li S, Li L, Wang Y, Yu H, Dai J, Yu B. Predictors of Adverse Prognosis in Patients With Acute Coronary Syndrome Caused by Plaque Erosion With a Nonstent Strategy. J Am Heart Assoc. 2022 Dec 20;11(24):e026414. doi: 10.1161/JAHA.122.026414. Epub 2022 Dec 19. PMID: 36533592; PMCID: PMC9798785.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...